MLase (PRIVATE.MLASE)

Overall impact
C (44)

Commentary

MLase is an average overall performer. With a 'C' rating of 43.8 for overall impact (30th percentile compared to all companies), MLase ranks 187th out of 193 industry peers, behind ConTIPI, Restoration Robotics, Corindus Vascular Robotics and 183 others, and ahead of Carestream Health, Xtant Medical, Nova Eye Medical and 3 others. On top material causes for MLase's industry (Health Care Equipment & Supplies), MLase performs well in Child and Maternal Health (94.8 score), Child and Maternal Health (94.8), Technology Innovation (94.8) and 6 other causes where it received an 'A' score and performs poorly in Disease Eradication (39.5 score), Fair Labor Practices (16.6), Accountable Institutions (37.6) and 27 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.MLASE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2007
Employees
24
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Bavaria, Germany
Share classes
PRIVATE.MLASE
Description
MLase AG is a world-leading provider of UV-light-based medical and industrial products. Since its founding in December 2007 by former employees of TuiLaser AG, the company has been developing and producing innovative and high-quality laser and light systems. These are the result of years of experience from a highly specialized team of experts. MLase AG offers its customers the highest possible quality.
Material causes
Ethos considers the following causes material for MLase, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.